Kiora Pharmaceuticals Statistics
NASDAQ: KPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7202-0.1008 (-12.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Kiora Pharmaceuticals by the numbers
Kiora Pharmaceuticals has a market capitalization of $3.2 million based on 4.42M shares outstanding. With trailing EPS of $-2.72, Kiora Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 65.8% below its 50-day average and 69.3% below its 200-day average.
Average daily trading volume is 35.23K shares, or about $25,374 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KPRX valuation vs. peer median
| Metric | KPRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.19M | $3.15M | +1% |
| Avg. volume | 35.23K | 252.61K | -86% |
Peer median across 8 companies: NRSN, MDCX, AZTR, APRE, GELS, SKYE, XBIO, JAGX.
Valuation
- Market cap
- $3.19M
- EPS (TTM)
- $-2.72
- Shares outstanding
- 4.42M
Price and trading
- Previous close
- 0.821
- Open
- 0.8155
- Day range
- 0.7202 – 0.8155
- 52-week range
- 0.72 – 2.91
- 52-week change
- -61.49%
- Beta
- —
- Volume
- 64.69K
- Average volume
- 35.23K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 3.19M
- Forward Pe
- -0.32
- Eps
- -2.72
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.91
- Week52 Low
- 0.72
- Avg Volume
- 35,232.00
- Shares Outstanding
- 4.42M
- Ma50
- 2.11
- Ma200
- 2.34
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -75.25%
- Pct From52w Low
- 0.03%